Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection

Pathology

Volumn 44, Issue 4, 2012, Pages 381-383

  BaAlawi, Fatma ^a   Robertson, Peter W ^a   Lahra, Monica ^a   Rawlinson, William D ^a,b,c  

^a New South Wales Government   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863645345     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328353bec0     Document Type: Article

References (12)

1. Lazzarotto T, Galli C, Pulvirenti R, et al. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol 2001; 8: 196-8. (Pubitemid 32065677)
2. Munro SC, Hall B, Whybin L, et al. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005; 43: 4713-8. (Pubitemid 41298268)
3. Wong A, Tank KH, Tee CS, Yeo GSH. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J 2000; 41: 151-5.
4. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol 2004; 29: 71-83. (Pubitemid 38121576)
5. Weber B, Prosser F, Munkwitz A, et al. Serological Diagnosis of cytomegalovirus infection: Comparison of 8 enzyme immunoassays for the detection of the detection of HCMV-specific IgM antibody. Clin Diagn Virol 1994; 2: 245-59. (Pubitemid 24235325)
6. Weber B, Berger A, Rabenau H. Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection. J Virol 2001; 96: 157-70. (Pubitemid 32607536)
7. Lagrou K, Bodeus M, Van Ranst M, et al. Evaluation of the new ARCHITECT CMV IgM, IgG and IgG avidity assays. J Clin Microbiol 2009; 47: 1695-9.
8. Daiminger A, Badder U, Egger M, et al. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women. J Clin Microbiol 1999; 13: 161-71. (Pubitemid 29349104)
9. Eggers M, Metzger C, Enders G. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralisation assay. J Med Virol 1998; 56: 352-8.
10. Blackburn NK, Besselaar TG, Schoub BD, et al. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol 1991; 33: 6-9.
11. Bland J, Altman D. Measurement in medicine: the analysis of method comparison studies. Statistician 1983; 32: 307-17.
12. Busse C, Strubel A, Schnitzler P. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies. J Clin Virol 2008; 43: 137-41.